Eintrag weiter verarbeiten
Buchumschlag von Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
Verfügbar über Open Access

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: OncoTargets and Therapy
Personen und Körperschaften: Kourie, Hampig Raphael, El Rassy, Elie, Clatot, Florian, de Azambuja, Evandro, Lambertini, Matteo
In: OncoTargets and Therapy, Volume 10, 2017, S. 3363-3372
Medientyp: E-Article
Sprache: Englisch
veröffentlicht:
Informa UK Limited
Schlagwörter:
author_facet Kourie, Hampig Raphael
El Rassy, Elie
Clatot, Florian
de Azambuja, Evandro
Lambertini, Matteo
Kourie, Hampig Raphael
El Rassy, Elie
Clatot, Florian
de Azambuja, Evandro
Lambertini, Matteo
author Kourie, Hampig Raphael
El Rassy, Elie
Clatot, Florian
de Azambuja, Evandro
Lambertini, Matteo
spellingShingle Kourie, Hampig Raphael
El Rassy, Elie
Clatot, Florian
de Azambuja, Evandro
Lambertini, Matteo
OncoTargets and Therapy
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
Pharmacology (medical)
Oncology
author_sort kourie, hampig raphael
spelling Kourie, Hampig Raphael El Rassy, Elie Clatot, Florian de Azambuja, Evandro Lambertini, Matteo 1178-6930 Informa UK Limited Pharmacology (medical) Oncology http://dx.doi.org/10.2147/ott.s122397 Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib OncoTargets and Therapy
doi_str_mv 10.2147/ott.s122397
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczEyMjM5Nw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczEyMjM5Nw
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint Informa UK Limited, 2017
imprint_str_mv Informa UK Limited, 2017
issn 1178-6930
issn_str_mv 1178-6930
language English
mega_collection Informa UK Limited (CrossRef)
match_str kourie2017emergingtreatmentsforher2positiveearlystagebreastcancerfocusonneratinib
publishDateSort 2017
publisher Informa UK Limited
recordtype ai
record_format ai
series OncoTargets and Therapy
source_id 49
title Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
title_unstemmed Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
title_full Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
title_fullStr Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
title_full_unstemmed Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
title_short Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
title_sort emerging treatments for her2-positive early-stage breast cancer: focus on neratinib
topic Pharmacology (medical)
Oncology
url http://dx.doi.org/10.2147/ott.s122397
publishDate 2017
physical 3363-3372
description
container_start_page 3363
container_title OncoTargets and Therapy
container_volume Volume 10
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792339869788274688
geogr_code not assigned
last_indexed 2024-03-01T15:54:59.568Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Emerging+treatments+for+HER2-positive+early-stage+breast+cancer%3A+focus+on+neratinib&rft.date=2017-07-01&genre=article&issn=1178-6930&volume=Volume+10&spage=3363&epage=3372&pages=3363-3372&jtitle=OncoTargets+and+Therapy&atitle=Emerging+treatments+for+HER2-positive+early-stage+breast+cancer%3A+focus+on+neratinib&aulast=Lambertini&aufirst=Matteo&rft_id=info%3Adoi%2F10.2147%2Fott.s122397&rft.language%5B0%5D=eng
SOLR
_version_ 1792339869788274688
author Kourie, Hampig Raphael, El Rassy, Elie, Clatot, Florian, de Azambuja, Evandro, Lambertini, Matteo
author_facet Kourie, Hampig Raphael, El Rassy, Elie, Clatot, Florian, de Azambuja, Evandro, Lambertini, Matteo, Kourie, Hampig Raphael, El Rassy, Elie, Clatot, Florian, de Azambuja, Evandro, Lambertini, Matteo
author_sort kourie, hampig raphael
container_start_page 3363
container_title OncoTargets and Therapy
container_volume Volume 10
description
doi_str_mv 10.2147/ott.s122397
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie, Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjE0Ny9vdHQuczEyMjM5Nw
imprint Informa UK Limited, 2017
imprint_str_mv Informa UK Limited, 2017
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 1178-6930
issn_str_mv 1178-6930
language English
last_indexed 2024-03-01T15:54:59.568Z
match_str kourie2017emergingtreatmentsforher2positiveearlystagebreastcancerfocusonneratinib
mega_collection Informa UK Limited (CrossRef)
physical 3363-3372
publishDate 2017
publishDateSort 2017
publisher Informa UK Limited
record_format ai
recordtype ai
series OncoTargets and Therapy
source_id 49
spelling Kourie, Hampig Raphael El Rassy, Elie Clatot, Florian de Azambuja, Evandro Lambertini, Matteo 1178-6930 Informa UK Limited Pharmacology (medical) Oncology http://dx.doi.org/10.2147/ott.s122397 Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib OncoTargets and Therapy
spellingShingle Kourie, Hampig Raphael, El Rassy, Elie, Clatot, Florian, de Azambuja, Evandro, Lambertini, Matteo, OncoTargets and Therapy, Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib, Pharmacology (medical), Oncology
title Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
title_full Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
title_fullStr Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
title_full_unstemmed Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
title_short Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
title_sort emerging treatments for her2-positive early-stage breast cancer: focus on neratinib
title_unstemmed Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
topic Pharmacology (medical), Oncology
url http://dx.doi.org/10.2147/ott.s122397